Helping doctors offer HIV prevention to teens
Part of Infections clinical trials.
This trial trains primary care providers at certain clinics to better offer PrEP, a daily pill that prevents HIV, to adolescents and young adults. If you are a provider at one of the listed clinics, you may be able to help improve how this prevention is delivered.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a primary care provider (doctor, nurse, or similar) at one of three specific clinics.
- The clinics are: Boston Children's Hospital Adolescent/Young Adult Medicine, Martha Eliot Health Center, or Children's Hospital Primary Care Center.
- There are no other restrictions to join this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
This study helps connect young people aged 13–24 to PrEP, a daily pill that prevents HIV. It tests whether offering PrEP in clinics or community locations makes it easier for you to get and stay on this prevention medication.
This study looks at ways to improve PrEP (pre-exposure prophylaxis) care by helping clinic staff track and support patients better. It's for healthcare workers, managers, and data staff at certain PrEP clinics.
This study tests if peer educators can help more students start PrEP, a daily pill that prevents HIV. If you are a student at one of the four listed colleges, you may be able to join.
This trial tests a program where HIV testing counselors help family planning patients learn about and get PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to access in clinics you may already visit.
This study helps healthcare providers and clinics deliver long-acting injectable PrEP (a preventive HIV medication given as an injection) more effectively. Researchers will study how clinics can better implement and offer this option to patients who need it.
Hear when a new PrEP trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.